Skip to main content
. 2013 Dec 13;18(1):56. doi: 10.1186/2047-783X-18-56

Figure 5.

Figure 5

The ratio of I 131 -PSCA-mAb in tumor to intramuscular I 131 -PSCA-mAb (T/NT) in the tumor-bearing nude mice at 1 h, 4 h, 8 h, 12 h and 24 h after intravenous injection of I 131 -PSCA-mAb.